Immunocore Holdings plc - ADR

NASDAQ:IMCR   4:00:00 PM EDT
62.81
+2.34 (+3.87%)
6:51:00 PM EDT: $63.44 +0.63 (+1.00%)
Earnings Announcements

Immunocore Reports Third Quarter 2022 Financial Results

Published: 11/09/2022 12:37 GMT
Immunocore Holdings plc - ADR (IMCR) - Immunocore Reports Third Quarter 2022 Financial Results and Provides Business Update.
Cash and Cash Equivalents of $387 Million As of September 30, 2022.
Qtrly Earnings per Share $0.13.
Q3 Earnings per Share View -28.80 Pence -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $51.18 Million
Adjusted EPS is expected to be -$0.07

Next Quarter Revenue Guidance is expected to be $52.48 Million
Next Quarter EPS Guidance is expected to be -$0.06

More details on our Analysts Page.